Mizuho analyst Christopher Parkinson raised the firm’s price target on Albemarle to $325 from $300 and keeps a Neutral rating on the shares. The analyst left the company’s strategic update more constructive on 2023 estimates. The firm is still bullish on intermediate-term demand, but sees Albemarle putting forth a higher bar verses what it anticipated into the event.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on ALB:
- Albemarle initiated with an Overweight at Piper Sandler
- Albemarle price target raised to $305 from $290 at Deutsche Bank
- Albemarle price target raised to $362 from $340 at RBC Capital
- Albemarle price target raised to $497 from $461 at Oppenheimer
- Albemarle price target raised to $305 from $298 at Baird